- Home
- BEAT vs PNI Comparison
BEAT vs PNI Comparison
Compare BEAT & PNI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BEAT
- PNI
- Stock Information
- Founded
- BEAT 2015
- PNI 2002
- Country
- BEAT United States
- PNI United States
- Employees
- BEAT 20
- PNI N/A
- Industry
- BEAT Retail: Computer Software & Peripheral Equipment
- PNI Trusts Except Educational Religious and Charitable
- Sector
- BEAT Technology
- PNI Finance
- Exchange
- BEAT Nasdaq
- PNI Nasdaq
- Market Cap
- BEAT 74.1M
- PNI 82.8M
- IPO Year
- BEAT 2021
- PNI N/A
- Fundamental
- Price
- BEAT $2.66
- PNI $7.34
- Analyst Decision
- BEAT Buy
- PNI
- Analyst Count
- BEAT 1
- PNI 0
- Target Price
- BEAT $8.00
- PNI N/A
- AVG Volume (30 Days)
- BEAT 282.2K
- PNI 26.4K
- Earning Date
- BEAT 11-07-2024
- PNI 01-01-0001
- Dividend Yield
- BEAT N/A
- PNI 4.76%
- EPS Growth
- BEAT N/A
- PNI N/A
- EPS
- BEAT N/A
- PNI N/A
- Revenue
- BEAT N/A
- PNI N/A
- Revenue This Year
- BEAT N/A
- PNI N/A
- Revenue Next Year
- BEAT N/A
- PNI N/A
- P/E Ratio
- BEAT N/A
- PNI N/A
- Revenue Growth
- BEAT N/A
- PNI N/A
- 52 Week Low
- BEAT $1.06
- PNI $6.03
- 52 Week High
- BEAT $3.48
- PNI $7.89
- Technical
- Relative Strength Index (RSI)
- BEAT 47.14
- PNI 34.12
- Support Level
- BEAT $2.28
- PNI $7.32
- Resistance Level
- BEAT $3.48
- PNI $7.65
- Average True Range (ATR)
- BEAT 0.29
- PNI 0.07
- MACD
- BEAT -0.05
- PNI -0.03
- Stochastic Oscillator
- BEAT 37.83
- PNI 0.00
About BEAT Heartbeam Inc.
HeartBeam Inc is a medical technology company primarily focusing on developing and commercializing higher resolution ambulatory Electrocardiogram ("ECG") solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility setting. The Company's ability to develop higher-resolution ECG solutions is achieved through the development of the Company's proprietary and patented Vector Electrocardiography ("VECG") technology platform. The Company has validated this technology and is seeking U.S. Food and Drug Administration ("FDA") clearance for its initial telehealth products.
About PNI Pimco New York Municipal Income Fund II of Beneficial Interest
PIMCO New York Municipal Income Fund II is a closed-end management investment company. Its investment objective is to seek to provide current income exempt from federal, New York State and New York City income tax. The fund portfolio of investments consists of investments in different sectors such as education, transportation, healthcare, and others.